Granite Investment Partners, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1542266 EL SEGUNDO, CA

Position in LGND

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$17,109,319

+$6,297,274 QoQ

Shares Held

54,128

-0.0% QoQ

Ownership

0.272%

of shares outstanding

% of Portfolio

0.90%

of 13F equity value

Holder Rank

#65

of 411 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Granite Investment Partners, LLC holds $85,167,773 across 14 Biotechnology names. LGND ranks #2 (20.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	80,124	$19,611,951
2	LGND	Ligand Pharmaceuticals Inc This page	54,128	$17,109,319
3	CORT	Corcept Therapeutics Inc	172,228	$14,975,224
4	KRYS	Krystal Biotech, Inc.	32,837	$12,204,527
5	TECH	BIO-TECHNE Corp	133,572	$9,436,861
6	VCEL	Vericel Corp	121,696	$5,414,255
7	HALO	Halozyme Therapeutics, Inc.	63,598	$4,977,815
8	IONS	Ionis Pharmaceuticals Inc	5,026	$398,511

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,109,319	54,128	-0.0%	Shares	Sole	2026-08-07
2026-03-31	$10,812,045	54,155	-6.5%	Shares	Sole	2026-04-30
2025-12-31	$10,952,068	57,926	-6.0%	Shares	Sole	2026-02-12
2025-09-30	$10,915,366	61,620	-50.5%	Shares	Sole	2025-11-10
2025-06-30	$14,148,840	124,462	-6.5%	Shares	Sole	2025-08-13
2025-03-31	$13,997,183	133,129	+15.2%	Shares	Sole	2025-05-13
2024-12-31	$12,379,896	115,538	-2.1%	Shares	Sole	2025-02-13
2024-09-30	$11,810,720	118,001	+219.7%	Shares	Sole	2024-11-12
2020-12-31	$3,671,095	36,914	-62.0%	Shares	Sole	2021-02-12
2020-09-30	$9,261,480	97,162	-51.5%	Shares	Sole	2020-11-06
2020-06-30	$22,415,404	200,406	+468.7%	Shares	Sole	2020-08-03
2020-03-31	$2,562,432	35,237	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.